¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Studies in family planning."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® family therapy ÇÑ±Û °¡Á·¿ä¹ý
¼³¸í   
  °¡Á·À» Ä¡·á ´ë»óÀ¸·Î Çϴ ½É¸®¿ä¹ý ÁßÀÇ Çϳª. °¡Á·ÁßÀÇ ¹®Á¦´Â ¹®Á¦¸¦ °¡Áø °³Àθ¸ÀÌ ¾Æ´Ï¶ó ¹®Á¦ °¡Á·À» ´ë»óÀ¸·Î ÇذáÇØ ³ª°¥ Çʿ䰡 Àִٴ ÀνÄÀ» ¹ÙÅÁÀ¸·Î ÇÏ¿© °¡Á· ÀüüÀÇ ½É¸®Àû ¼º¼÷À» ¸ñÇ¥·Î ÇÑ ¿ä¹ýÀÌ´Ù. Å©°Ô ³ª´©¾î °¡Á· ÁßÀǠƯÁ¤ÀÎÀ» ´ë»óÀ¸·Î ÇÏ¿© °¢°¢ ´Ù¸¥ µ¶¸³µÈ Ä¡·á¸¦ Çϴ º´Çà½É¸®¿ä¹ý°ú °¡Á· Àüü¸¦ µ¿½Ã ¸éÁ¢Çϴ ¹æ¹ýÀ» ÁַΠÇϴ ÇÕµ¿°¡Á·¿ä¹ýÀÌ Àִµ¥, Æ¯È÷ ÈÄÀÚ¸¦ °¡¸®ÄÑ °¡Á·¿ä¹ý À̶ó°í Çϴ °æ¿ì°¡ ¸¹´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • family planning
    °¡Á·°èȹ
  • planning
    °èȹ
  • autonomous nuclear family
    ÀÚÀ²ÇÙ°¡Á·
  • family
    1. °¡Á· 2. ±º
  • family crisis
    °¡Á·À§±â
  • family history
    °¡Á··Â
  • family medicine
    °¡Á¤ÀÇÇÐ
  • family schism
    °¡Á·ºÐ¿­
  • family study
    °¡Á·Á¶»ç
  • family system theory
    °¡Á·Ã¼°è·Ð
  • gene family
    À¯ÀüÀÚ±º
  • hierarchical family tree
    °èÅë°¡°è¼ö, °èÅë°¡°è³ª¹«
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • family
    °¡Á·
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • family planning
    °¡Á·°èȹ
  • planning
    °èȹ
  • planning target volume
    °èȹǥÀûºÎÇÇ
  • treatment planning
    Ä¡·á°èȹ
  • autonomous nuclear family
    ÀÚÀ²ÇÙ°¡Á·
  • family crisis
    °¡Á·À§±â
  • family
    °¡Á·
  • family history
    °¡Á··Â
  • family schism
    °¡Á·ºÐ¿­
  • family study
    °¡Á·Á¶»ç
  • family system theory
    °¡Á·Ã¼°è·Ð
  • hierarchical family tree
    °èÅë°¡°è¼ö, °èÅë°¡°è³ª¹«
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gastric acid secretory studies
    À§»êºÐºñ °Ë»ç.
  • planning
    °èȹ
  • planning target volume
    °èȹ¿ë Ç¥ÀûºÎÇÇ
  • real-time studies
    ½Ç½Ã°£ °Ë»ç (ãùãÁÊà ËþÞÛ)
  • Family
    °ú (ºÐ·ùÇÐÀÇ)
  • hierarchial family tree
    °èÅë°¡°è¼ö
  • immunoglobulin supergene family
    ¸é¿ª±Û·ÎºÒ¸° À¯ÀüÀÚÃʰŴëÁý´Ü
  • infantile amaurotic family idiocy
    ¿µ¾ÆÈæ³»À强 °¡Á·¼º ¹éÄ¡.
  • infantile amaurotic family idiocy
    ¿µ¾ÆÈæ³»À强 °¡Á·¼º ¹éÄ¡.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • family planning
    °¡Á·°èȹ.
  • gastric acid secretory studies
    À§»êºÐºñ °Ë»ç.
  • real-time studies
    ½Ç½Ã°£ °Ë»ç (ãùãÁÊà ËþÞÛ)
  • computer planning
    ÄÄÇ»ÅÍÀü»êÈ­Ä¡·á°èȹ
  • permanency planning
  • planning
    °èȹ
  • planning target volume
    °èȹ¿ë Ç¥ÀûºÎÇÇ
  • three-dimensional treatment planning
    »ïÂ÷¿øÄ¡·á°èȹ
  • treatment planning
    Ä¡·á°èȹ
  • autonomous nuclear family
    ÀÚÀ²¼º ÇÙ°¡Á·.
  • degenerate family
    ÅðÈ­°¡°è(÷Üûùʫͪ).
  • degenerate family
    ÅðÈ­°¡°è(̴̬˧˭).
  • family
    °ú, °¡Á·.
  • family crisis
    °¡Á·À§±â(Ê«ðéêËѦ)
  • family history
    °¡Á·°ú,°¡Á··Â(˧̡Ëç).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • code word family
    ºÎÈ£(ݬûÜ)±ÛÀÚÁ·(ðé)
  • gene family
    À¯ÀüÀÚ Á·(ë¶îîí­ðé)
  • multigene family
    ´ÙÀ¯ÀüÀÚ°¡Á·(Òýë¶îîí­Ê«ðé)
  • repeated gene family
    ¹Ýº¹ À¯ÀüÀÚ °¡Á·(ë¶îîí­Ê«ðé)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • family planning
    °¡Á·°èȹ
  • family
    °¡Á·
  • family history
    °¡Á··Â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FP false positive; family physician; family planning; family practice; family practitioner; Fanconi pan...
FPA Family Planning Association; fibrinopeptide A; filter paper activity; fluorophenylalanine
FPC familial polyposis coli; family planning clinic; fish protein concentrate
NRSFPS National Reporting System for Family Planning Services
AAFP American Academy of Family Physicians; American Academy of Family Practice
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FP Family Planning
FPC Family Planning Clinic
NFP Natural Family Planning
PTV Planning Target Volume
TPS Treatment Planning Systems
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 7621
    JournalTitle: Studies in family planning.
    MedAbbr: Stud Fam Plann
    ISSN: 0039-3665
    ESSN:
    IsoAbbr:
    NlmId: 7810364
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • family planning
    °¡Á· °èȹ
    Àα¸ÀÇ Áõ°¡·Î ÀÎÇØ ¹ß»ýµÈ ¿ë¾î·Î ÇÙ°¡Á· ½Ã´ëÀÇ ºÎºÎ¿¡°Ô ÀÚ³àÀÇ ¼ö¸¦ Á¦ÇÑÇÏ´Â ÀÏ·ÃÀÇ °èȹÀ» ¸»Çϸç, ¼º °ü°è¿¡¼­ÀÇ ÇÇÀÓÀ̳ª, ¹è¶õÀÏ Á¶Àý µîÀÇ ¹æ¹ýÀ¸·Î Àα¸ ¹Ðµµ°¡ ³ôÀº ±¹°¡¿¡¼­ ¸¹ÀÌ ÇàÇØÁö°í ÀÖ´Ù.
  • planning incision
    Àý°³ °èȹ
  • treatment planning
    Ä¡·á °èȹ, Ä¡·á °èȹ ¼ö¸³
  • degenerate family
    ÅðÈ­ °¡°è
  • family
    °ú, °¡Á·
    »ý¹° ºÐ·ùÇлó ¸ñ°ú ¼ÓÀÇ Áß°£ Á·.
  • family history
    °¡Á··Â
    ȯÀÚ¸¦ Áø´ÜÇϱâ Àü ȯÀÚ¿ÍÀÇ ¸é´ã½Ã Áú¹®ÇÏ´Â °ÍÀ¸·Î À¯ÀüÀû Áúº´ÀÇ °¡´É¼ºÀ̳ª °¨¿°ÁõÀ» ¾Ë¾Æº¸±â À§ÇØ ½Ç½ÃÇÑ´Ù.
  • family record
    °¡Á· ±â·Ï
  • family tree
    °¡°è
    µ¿ÀǾî=
  • herpes family virus
    Æ÷Áø¼º ¹ÙÀÌ·¯½º
    6±ºÀ¸·Î ºÐ·ùµÈ´Ù.
  • menanoma family
    Èæ»öÁ¾ °ú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
family planning Programs or services designed to assist the family in controlling reproduction by either improving or diminishing fertility.
(12 Dec 1998)
family planning policy A course or method of action selected, usually by a government, to guide and determine present and future decisions on population control by limiting the number of children or controlling fertility, notably through family planning and contraception within the nuclear family.
(12 Dec 1998)
retrospective studies Studies used to test aetiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
(12 Dec 1998)
pharmalogical studies <pharmacology> Studies to assess the potential harmful or other effects of drugs
(16 Dec 1997)
clinical studies <pharmacology> Human studies that are designed to measure the safety, efficacy, and appropriate dosage of a new drug or biological. Clinical studies routinely involve the use of a placebo group that is given an inactive substance that looks like the test product.
(14 Nov 1997)
cohort studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesised to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.
(12 Dec 1998)
combination studies <pharmacology> Studies in which a new drug is evaluated in combination with existing drugs.
(09 Jan 1998)
multicenter studies Controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children.
(12 Dec 1998)
multivariate studies The use of statistical techniques for the simultaneous investigations of the influence of several variables.
(05 Mar 2000)
preclinical studies <pharmacology> Studies in which a drug is tested on animals and in other non-human test systems. Safety information from such studies are used to support an investigational new drug application.
(14 Nov 1997)
sampling studies Studies in which a number of subjects are selected from all subjects in a defined population. Conclusions based on sample results may be attributed only to the population sampled.
(12 Dec 1998)
prospective studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
(12 Dec 1998)
his bundle studies <cardiology> This test studies the electrical activity of the bundle of HIS.
The bundle of HIS is a group of electrical fibres in the heart that are responsible for transmitting the electrical impulses which generate a normal cardiac contraction. This test may be performed in cases of cardiac arrhythmias, to locate a specific area responsible for a conduction defect and to determine the need for cardiac pacemaker placement.
The test involves the passage of a an electrode tipped catheter into the heart. This catheter is usually threaded through a neck, arm or chest vein. Measurements of the HIS bundle can then be performed while standard ECG leads are placed on the arms and legs.
This test carries a small risk of bleeding, arrhythmias, embolism, heart attack and stroke. It is performed by a specially trained cardiologist.
(27 Sep 1997)
immunofluorescent studies <technique> A special assay that relies on the production of measurable fluorescent light. An immunofluorescent tagged antibody interacts and binds with an antigen allowing an indirect measurement of its concentration.
(27 Sep 1997)
intervention studies Epidemiologic investigations designed to test a hypothesised cause-effect relation by modifying the supposed causal factor(s) in the study population.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • family planning
    °¡Á·°èȹ
  • International Institute for Strategic Studies
    (¿µ)±¹Á¦ Àü·«¿¬±¸¼Ò(I.I.S.S)
  • peace studies
    ÆòÈ­ ¿¬±¸(°­ÁÂ)
  • Economic Planning Board
    °æÁ¦ ±âȹ¿ø(Çѱ¹)
  • city plan (planning)
    µµ½Ã°èȹ
  • crew activity planning
    (¿ìÁÖ¼± ºñÇàÁßÀÇ) ½Â¹«¿ø ÀÛ¾÷°èȹ
  • land planning
    ±¹Åä°èȹ
  • planning
    °èȹ;Æò¸é °èȹ;°èȹȭ
  • town planning
    µµ½Ã°èȹ
  • family
    °¡Á·
  • Holy Family
    ¼º°¡Á·(¼º¸ð ¸¶¸®¾ÆÀÇ ÆÈ¿¡ ¾È±ä ¾î¸° ¿¹¼ö,¿ä¼Á,¾î¸° ¼º¿äÇÑ µîÀ» Ç¥ÇöÇÑ ±×¸²,Á¶°¢)
  • county family
    ÁÖ(Áö¹æ)ÀÇ ¸í¹®
  • extended family
    (»çȸ)È®´ë °¡Á·(±ÙÄ£À» Æ÷ÇÔÇÑ °Í)
  • family
    °¡±¸;¼¼´ë;°¡Á·;Áý¾È;½Ä±¸µé;¾ÆÀ̵é;ÀÚ³à;Á¾Á·;¹ÎÁ·;ÀÏÁ·;°¡¹®;ģô;Àϰ¡;Áý¾È
  • family
    °¡Á·;½Ä±¸;Àϰ¡;ÇÑÁý¾ÈÀÇ ¾ÆÀ̵é;ÀÏÁ·;¹®¹ú;¸í¹®
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á